Breden T G, Berg R, Plotka E D
Department of Reproductive Physiology, Marshfield Medical Research and Education Foundation, Wisconsin.
J Androl. 1996 Jul-Aug;17(4):443-8.
The purpose of this study was to increase the accuracy and reproducibility of the acrosin amidase assay and to assess the effects of different methods of sperm isolation on total sperm acrosin activity. Specific acrosin activity was measured by the procedure described by Kennedy et al (1989) comparing the usual substrate, N-alpha-benzoyl-DL-arginine-p-nitroanalide hydrochloride (DL-BAPNA) with the L-(L-BAPNA) and D-(D-BAPNA) isomers. Activity measurements were also compared on sperm isolated by methods: (1) centrifugation through buffered Ficoll, (2) method 1 plus an additional wash in buffered Ficoll, (3) back addition of supernatant from method 1 to spermatozoa isolated by method 2, and (4) swim-up into synthetic human tubal fluid media (mHTF) and using L-BAPNA. The specific activity of acrosin was dependent on substrate concentration up to 2.1 mM DL-BAPNA and 2 mM L-BAPNA. The maximum reliable solubility of DL-BAPNA was approximately 2.1 mM in 10% dimethylsulfoxide (DMSO):90% detergent buffer. There were no solubility constraints for L-BAPNA through 6.3 mM (> 5 times Km). D-BAPNA (1 mM) was not hydrolyzed by acrosin. Mean specific acrosin activity was higher using 6.3 mM L-BAPNA (159 +/- 11.4 microIU/10(6) sperm) than with 2.1 mM DL-BAPNA (81.4 +/- 10.9 microIU/10(6) sperm; P < 0.001, n = 16). Sperm isolated by methods 2 and 4 had higher specific acrosin activity than sperm isolated by method 1 (P = 0.002). Sperm treated per method 3 had similar acrosin activity as sperm isolated by method 1 (140 +/- 14.1 vs. 149 +/- 13.8 microIU/10(6) sperm). The K(m) for acrosin, calculated through 6.3 mM L-BAPNA, was 0.6 microIU/10(6) sperm. L-BAPNA is superior to DL-BAPNA as substrate for a clinical acrosin assay, increasing the reproducibility and accuracy of the assay. Simple Ficoll separation is not completely effective at removing acrosin inhibitors and additional separation steps may be necessary to assess true acrosin activity.
本研究的目的是提高顶体蛋白酶活性测定的准确性和可重复性,并评估不同精子分离方法对总精子顶体酶活性的影响。采用肯尼迪等人(1989年)描述的方法,将常用底物N-α-苯甲酰-DL-精氨酸对硝基苯胺盐酸盐(DL-BAPNA)与L-(L-BAPNA)和D-(D-BAPNA)异构体进行比较,测定特异性顶体蛋白酶活性。还比较了通过以下方法分离的精子的活性测量结果:(1)通过缓冲的菲可溶液离心;(2)方法1加上在缓冲的菲可溶液中额外洗涤一次;(3)将方法1的上清液回加至通过方法2分离的精子中;(4)上游至合成人输卵管液培养基(mHTF)中并使用L-BAPNA。顶体蛋白酶的比活性在DL-BAPNA浓度高达2.1 mM和L-BAPNA浓度高达2 mM时依赖于底物浓度。在10%二甲基亚砜(DMSO):90%去污剂缓冲液中,DL-BAPNA的最大可靠溶解度约为2.1 mM。L-BAPNA在6.3 mM(>5倍Km)时没有溶解度限制。D-BAPNA(1 mM)不会被顶体蛋白酶水解。使用6.3 mM L-BAPNA时的平均特异性顶体蛋白酶活性(159±11.4微国际单位/10⁶精子)高于使用2.1 mM DL-BAPNA时(81.4±10.9微国际单位/10⁶精子;P<0.001,n = 16)。通过方法2和4分离的精子比通过方法1分离的精子具有更高的特异性顶体蛋白酶活性(P = 0.002)。按照方法3处理的精子与通过方法1分离的精子具有相似的顶体蛋白酶活性(140±14.1对149±13.8微国际单位/10⁶精子)。通过6.3 mM L-BAPNA计算的顶体蛋白酶的K(m)为0.6微国际单位/10⁶精子。作为临床顶体蛋白酶测定的底物,L-BAPNA优于DL-BAPNA,可提高测定的可重复性和准确性。简单的菲可分离在去除顶体蛋白酶抑制剂方面并不完全有效,可能需要额外的分离步骤来评估真正的顶体蛋白酶活性。